Addiction to Golgi-resident PI4P Synthesis in Chromosome 1q21.3-amplified Lung Adenocarcinoma Cells
Overview
Authors
Affiliations
A chromosome 1q21.3 region that is frequently amplified in diverse cancer types encodes phosphatidylinositol (PI)-4 kinase IIIβ (PI4KIIIβ), a key regulator of secretory vesicle biogenesis and trafficking. Chromosome 1q21.3-amplified lung adenocarcinoma (1q-LUAD) cells rely on PI4KIIIβ for Golgi-resident PI-4-phosphate (PI4P) synthesis, prosurvival effector protein secretion, and cell viability. Here, we show that 1q-LUAD cells subjected to prolonged PI4KIIIβ antagonist treatment acquire tolerance by activating an miR-218-5p-dependent competing endogenous RNA network that up-regulates PI4KIIα, which provides an alternative source of Golgi-resident PI4P that maintains prosurvival effector protein secretion and cell viability. These findings demonstrate an addiction to Golgi-resident PI4P synthesis in a genetically defined subset of cancers.
The cancer-associated secretory phenotype: a new frontier in targeted therapeutics.
Tan X, Xiao G, Banerjee P, Wang S, Kurie J J Clin Invest. 2024; 134(17).
PMID: 39225096 PMC: 11364386. DOI: 10.1172/JCI182652.
: a novel potential therapeutic target for lung cancer.
Baldavira C, Prieto T, Nagai M, Capelozzi V Transl Lung Cancer Res. 2024; 13(1):199-204.
PMID: 38404996 PMC: 10891409. DOI: 10.21037/tlcr-23-734.
Zhang A, He X, Zhang C, Tang X BMC Med Genomics. 2024; 17(1):53.
PMID: 38365684 PMC: 10870608. DOI: 10.1186/s12920-024-01823-9.
Lu Y, He W, Huang X, Xiao X BMC Cancer. 2024; 24(1):55.
PMID: 38200409 PMC: 10777557. DOI: 10.1186/s12885-024-11841-6.
Construction and validation of an efferocytosis-related prognostic signature in lung adenocarcinoma.
Liu J, Wei L J Cancer Res Clin Oncol. 2023; 149(16):14577-14596.
PMID: 37578523 DOI: 10.1007/s00432-023-05251-7.